v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flow from operating activities:    
Net loss $ (7,637) $ (7,097)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 194 122
Stock-based compensation expense 592 531
Issuance of common stock to vendor 253 55
Right-of-use asset amortization 201 197
Loss on foreign currency transactions 283 (66)
Transaction costs allocable to warrants   198
Change in fair value of the warrant liability (672) (461)
Change in operating assets and liabilities:    
Accounts receivable 269 (24)
Research and development tax credit receivable (499) 697
Prepaid expenses and other current assets 43 (159)
Other non-current assets 1  
Accounts payable and accrued expenses 149 713
Lease liabilities (166) (201)
Income tax payable   (23)
Other current liabilities (20) (102)
Net cash used in operating activities (7,009) (5,620)
Cash flows from investing activities:    
Purchases of property, plant and equipment (75) (12)
Net cash used by investing activities (75) (12)
Cash flow from financing activities:    
Proceeds from the issuance of preferred stock in private placement   12,386
Proceeds from the issuance of warrants in private placement   1,763
Payment of issuance costs   (1,483)
Proceeds from the exercise of warrants 3 25
Net cash provided by financing activities 3 12,691
Effect of exchange rate changes on cash 28 (84)
Net change in cash (7,053) 6,975
Cash, beginning of period 8,836 4,235
Cash, end of period 1,783 11,210
Supplemental disclosure of cash and non-cash investing and financing activities    
Issuance of common shares for consulting services 253 55
Initial classification of fair value of warrants   1,837
Right-of-use asset and lease liability additions $ 82 $ 50

Source

HTML PDF
ZIP